JohnHorlanderMD

PubMed

• 25 citations
  Diltiazem inhibits human intestinal cytochrome P450 3A (CYP3A) activity in vivo without altering the expression of intestinal mRNA or protein
  Amar G. Pinto, John C. Horlander, Naga Chalasani, Mitchell A. Hamman, Ali Asghar, Dhanashri Kolwankar, Stephen D. Hall> ;British Journal of Clinical Pharmacology. 2005 Apr 1
• 59 citations
  Effects of Albumin/Furosemide Mixtures on Responses to Furosemide in Hypoalbuminemic Patients
  Naga Chalasani, J. Christopher Gorski, John C. Horlander, Rebecca Craven, Helena Hoen, Juan F. Maya, D. Craig Brater> ;Journal of the American Society of Nephrology. 2001 May 1
• 1 citations
  Effect of albumin-furosemide mixtures on response to furosemide in cirrhotic patients with ascites.
  D. C. Brater, Naga Chalasani, J. C. Gorski, John C. Horlander, Rebecca Craven, Helena Hoen, Juan F. Maya> ;Transactions of the American Clinical and Climatological Association. 2001 Jan 1
• 102 citations
  Screening for hepatocellular carcinoma in patients with advanced cirrhosis
  Naga Chalasani, John C. Horlander, Areen Said, Helena Hoen, Kenyon K. Kopecky, Stephan M. Stockberger, Rajesh Manam, Paul Y. Kwo, Lawrence Lumeng> ;The American Journal of Gastroenterology. 1999 Oct 1
• Positron emission tomography for detecting occult hepatocellular carcinoma in hepatitis C cirrhotics awaiting for liver transplantation.
  Liangpunsakul, S., Agarwal, D., Horlander, J. C., Kieff, B., Chalasani, N.> ;Transplant Proc. 2003 Dec
• Vaccination against hepatitis B in patients with chronic liver disease awaiting liver transplantation.
  Horlander, J. C., Boyle, N., Manam, R., Schenk, M., Herring, S., Kwo, P. Y., Lumeng, L., Chalasani, N.> ;Am J Med Sci. 1999 Nov
• Join now to see all